Empowered Funds’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22M | Buy |
118,692
+9,066
| +8% | +$1.68M | 0.25% | 75 |
|
|
2025
Q1 | $23M | Buy |
109,626
+12,448
| +13% | +$2.61M | 0.33% | 44 |
|
|
2024
Q4 | $17.3M | Buy |
97,178
+15,934
| +20% | +$2.83M | 0.25% | 65 |
|
|
2024
Q3 | $16M | Sell |
81,244
-9,361
| -10% | -$1.85M | 0.25% | 72 |
|
|
2024
Q2 | $15.5M | Buy |
90,605
+45,606
| +101% | +$7.82M | 0.27% | 58 |
|
|
2024
Q1 | $8.19M | Sell |
44,999
-32,584
| -42% | -$5.93M | 0.15% | 168 |
|
|
2023
Q4 | $12M | Buy |
77,583
+8,438
| +12% | +$1.31M | 0.3% | 45 |
|
|
2023
Q3 | $10.3M | Buy |
69,145
+46,348
| +203% | +$6.91M | 0.3% | 46 |
|
|
2023
Q2 | $3.07M | Buy |
22,797
+72
| +0.3% | +$9.7K | 0.11% | 263 |
|
|
2023
Q1 | $3.62M | Buy |
+22,725
| New | +$3.62M | 0.21% | 136 |
|
|
2022
Q4 | – | Sell |
-8,436
| Closed | -$1.13M | – | 228 |
|
|
2022
Q3 | $1.13M | Sell |
8,436
-10,214
| -55% | -$1.37M | 0.11% | 155 |
|
|
2022
Q2 | $2.86M | Buy |
18,650
+12,630
| +210% | +$1.93M | 0.37% | 89 |
|
|
2022
Q1 | $976K | Buy |
6,020
+212
| +4% | +$34.4K | 0.11% | 188 |
|
|
2021
Q4 | $786K | Buy |
5,808
+763
| +15% | +$103K | 0.09% | 174 |
|
|
2021
Q3 | $544K | Buy |
5,045
+2,209
| +78% | +$238K | 0.07% | 168 |
|
|
2021
Q2 | $319K | Buy |
+2,836
| New | +$319K | 0.04% | 206 |
|
|
2019
Q4 | – | Sell |
-32,296
| Closed | -$2.45M | – | 103 |
|
|
2019
Q3 | $2.45M | Buy |
+32,296
| New | +$2.45M | 1.06% | 11 |
|
|
2018
Q2 | – | Sell |
-10,276
| Closed | -$969K | – | 93 |
|
|
2018
Q1 | $969K | Buy |
10,276
+375
| +4% | +$35.4K | 0.35% | 91 |
|
|
2017
Q4 | $958K | Buy |
+9,901
| New | +$958K | 0.48% | 62 |
|